Nanobody Discovery
Yeast surface display enables quantitative screening of VHH candidates by linking displayed binders with their encoding sequences. At NBbiolab, our Yeast Display VHH Screening Service combines high-diversity VHH libraries with magnetic enrichment and fluorescence-activated cell sorting to progressively identify candidates with the desired binding characteristics.
Screening strategies can be tailored according to project objectives, including binding strength, specificity, epitope competition, and other defined selection criteria. Enriched VHH populations can be further analyzed by monoclonal sequencing or NGS, followed by recombinant expression and binding validation of selected candidates.
The service can support projects starting from custom immune VHH libraries or suitable existing libraries and can connect with downstream affinity maturation, humanization, and antibody engineering. This creates an integrated path from Yeast Library Screening to validated candidates within a broader VHH Binder Discovery workflow.
When to Use Yeast Display for Nanobody Discovery
Yeast display is particularly advantageous for: Discovery of high-affinity VHH bindersScreening against soluble protein antigensQuantitative affinity-based selectionAffinity maturation of existing nanobody candidatesScreening libraries with precise control of binding conditions
Yeast Display VHH Screening Capabilities
NBbiolab provides an integrated Yeast Display VHH Screening Service for the identification and selection of target-specific VHH binders. Based on our Yeast Surface Display Platform , the screening strategy combines high-diversity VHH libraries, magnetic enrichment, multi-parameter FACS sorting, and sequence analysis to progressively enrich candidates with the desired binding profile.
